BIM
HPTX

BlackRock Investment Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock Investment Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-40,916
Closed -$1.88M – 4305
2015
Q1 		$1.88M Buy
40,916
+237
+0.6% +$7.09K ﹤0.01% 2071
2014
Q4 		$976K Sell
40,679
-385
-0.9% -$8.68K ﹤0.01% 2563
2014
Q3 		$1.04M Sell
41,064
-2,143
-5% -$53.2K ﹤0.01% 2500
2014
Q2 		$1.13M Buy
43,207
+19,662
+84% +$505K ﹤0.01% 2517
2014
Q1 		$607K Buy
23,545
+246
+1% +$6.67K ﹤0.01% 2846
2013
Q4 		$471K Sell
23,299
-508
-2% -$12K ﹤0.01% 2974
2013
Q3 		$622K Buy
23,807
+1,901
+9% +$47.6K ﹤0.01% 2784
2013
Q2 		$482K Buy
+21,906
New +$480K ﹤0.01% 2871

BlackRock Investment Management's HPTX Position: Q2 2015 in Review

BlackRock Investment Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 40,916 shares — an estimated $1.88M sold.

BlackRock Investment Management first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $1.88M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock Investment Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 40,916 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $1.88M.
  • BlackRock Investment Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock Investment Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.88M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.